People | September 04, 2024
Enzene appoints new site lead of biologics manufacturing
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
Ordspono is Regeneron’s first approved bispecific antibody and will provide an off-the-shelf option that can be administered in the out-patient setting, with hope for complete remission
The emergence of new infections in India is a growing concern
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
Dr. Vinod Kumar Paul highlighted the huge gap between the demand for and supply of organs
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Subscribe To Our Newsletter & Stay Updated
